Robert M. Davis - May 2, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chairman, CEO & President, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Robert M. Davis
Stock symbol
MRK
Transactions as of
May 2, 2023
Transactions value $
$0
Form type
4
Date filed
5/4/2023, 06:11 PM
Previous filing
Apr 28, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 272K May 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +187K $0.00 187K May 2, 2023 Common Stock 187K $117.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.